The Israeli Drugmaker, Teva Pharmaceutical rushes to send its Malaria drug to Covid-19 patients in U.S. hospitals following encouraging results from China and France. Teva said 6 million tablets will be delivered to U.S. hospitals by March 31, and more than 10 million in a month.
Teva Pharmaceutical Industries Ltd. said it plans to donate more than 10 million tablets of hydroxychloroquine sulfate, a malaria drug touted by President Donald Trump as a potential treatment for the coronavirus, to help U.S. hospitals meet a potential surge in demand.
The Israeli company is one of the world’s largest makers of hydroxychloroquine, a less-toxic version of chloroquine, which is used in malaria, rheumatoid arthritis and lupus. Continue Reading »
Israeli researchers in the Upper Galilee are currently establishing parameters, permitting the safety approvals that will enable the Galilee Research Institute’s preclinical testing of a coronavirus vaccine.
A group of Israeli researchers at the Galilee Research Institute (MIGAL) are close to developing a coronavirus vaccine that could be ready in three weeks and available within 90 days, according to Israeli Minister of Science and Technology Ofir Akunis.
The research team has already created a vaccine against avian Coronavirus Infectious Bronchitis Virus (IBV), and are adapting it to create a human vaccine against Coronavirus (COVID-19), according to The Jewish Press. Continue Reading »
In collaboration with Dr. Talia Golan’s team at the Cancer Research Center at Sheba Medical Center, a study, led by Prof. Malka Cohen-Armon and her team at TAU’s Sackler Faculty of Medicine have successfully eradicated the number of cancerous cells by up to 90% after two weeks of daily injections.
A new treatment developed by Tel Aviv University could induce the destruction of pancreatic cancer cells, eradicating the number of cancerous cells by up to 90% after two weeks of daily injections of a small molecule known as PJ34.
Cancerous cells forming a lump in the pancreatic tissue.
A new protocol developed by Tel Aviv University researchers using nanotechnology that proved effective in preventing melanoma tumors in mice could lead to a major breakthrough in the treatment of far more dangerous skin cancers.
By Tsvi Sadan
Nature Nanotechnology published on August 5 a study led by Prof. Ronit Satchi-Fainaro, chair of the Department of Physiology and Pharmacology and head of the Laboratory for Cancer Research and Nanomedicine at Tel Aviv Universality’s Sackler Faculty of Medicine, and Prof. Helena Florindo of the University of Lisbon, while on sabbatical at the Satchi-Fainaro lab at Tel Aviv University.
The new MRI technique developed by Hebrew University of Jerusalem researchers is especially important for understanding whether a patient is merely getting older or is developing a disease such as Parkinson’s or Alzheimer’s.
MRI, or magnetic resonance imaging, already does pretty amazing work giving us a better picture of what’s happening on our insides. But it is about to do even more amazing work, helping doctors determine more quickly the onset of neurodegenerative diseases.
A team of researchers from the Hebrew University of Jerusalem, led by Dr. Aviv Mezer, found a way for MRIs to record changes in the biological makeup of brain tissue. Continue Reading »
When David Groberman’s wife, Odelia, was pregnant with their third child, some concerns sent the couple scurrying from one medical appointment to the next.
After arranging for babysitting, driving to the appointment, finding parking, and waiting, the actual fetal monitoring exam took only several minutes – and then came another round of waiting for the physician to analyze results.
The research, conducted by Dr. Talia Golan, head of Sheba Medical Center’s Pancreatic Cancer Center, developed a new treatment for the 4th leading cause of cancer deaths. – Dr. Talia Golan, “This treatment also exemplifies the advent of ‘precision medicine’ based on a specific genetic biomarker, BRCA 1 and 2.”
A Chaim Sheba Medical Center researcher has discovered a potential treatment for metastatic pancreatic cancer.
“In the history of oncology, there have been only two or three studies that have shown some benefits for pancreatic cancer,” said Dr. Raanan Berger, head of Oncology for Sheba Medical Center, the country’s largest hospital, located in the Tel HaShomer neighborhood of Ramat Gan. Continue Reading »
Jibril Rajoub, an avid supporter for violent terror attacks against Israelis, has been admitted to Ichilov hospital in Tel Aviv, despite the Palestinian Authority’s announcement 2 months ago that it discontinued all medical treatments in Israel for Palestinians.
By The JERUSALEM POST STAFF
Senior Palestinian leader Jibril Rajoub is currently undergoing treatment at an Israeli hospital, Palestinian Media Watch reported on Tuesday.
According to the organization, Rajoub has repeatedly expressed his support for terror attacks and violence against Israelis, while emphasizing the importance of maintaining the backing of the international community. For this reason, he opposed suicide bombings in Tel Aviv, while encouraging targeting soldiers and settlers. Continue Reading »
REPORT: “Sheba Medical Center (or Tel HaShomer Hospital) in Tel Aviv is a leader in medical science and biotechnical innovation, both in the Middle East and worldwide….and serves over 1 million patients per year.”
By Arutz Sheva Staff
Newsweek magazine has tabbed Sheba Medical Center at Tel Hashomer as one of the top 10 hospitals in the world, as part of its special “Best Hospitals in the World” edition.
According to Newsweek, “We partnered with Statista Inc., a global market research and consumer data company, to develop a groundbreaking ranking of the world’s best hospitals.”
“The hospitals on this list are at the forefront of adapting to these new challenges while providing top-notch patient care…The hospitals on our list are all world leaders in health care, but these are the very best – the top 10, according to Newsweek’s panel of doctors, medical professionals and administrators across four continents.” Continue Reading »
A team of Hebrew University of Jerusalem scientists used an award-winning algorithm to identify 27 molecules with the significant potential for the treatment of obesity, fatty liver disease, among other ailments.
In a newly published study in Scientific Reports, a team from Hebrew University of Jerusalem’s Institute for Drug Research reports its discovery of 27 new molecules that activate a protein called PPAR-delta, which has the potential to increase physical endurance and trim waistlines by getting muscle cells to burn more fat.
These molecules therefore hold promise for the treatment of fatty liver disease and obesity, among other ailments. Continue Reading »
Rambam Health Care Campus of Haifa and the Global Center for Medical Innovation (GCMI) – an affiliate of the Georgia Institute of Technology — are partnering to start a med-tech incubator for Israeli-based companies in Atlanta.
GCMI, along with Rambam doctors and specialists from various fields, will provide advice and consultation to Israeli companies at the new Biomedical and Digital Health Innovation Center to help them obtain funding, navigate commercialization and regulatory clearance and other necessities for entering the US healthcare market. Continue Reading »
Being developed for oral use, not an injection, the ground-breaking treatment for acute myeloid leukemia will accomplish the work of 3-4 separate drugs, reduce cancer patients’ need for radical procedures and eliminate some unbearable side effects. • The Hebrew University of Jerusalem researchers are trying to expand the drug’s use to other cancers.
By Ran Reznick, Erez Linn, Maytal Yasur Beit-Or & Israel Hayom Staff
Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough biological drug to treat people suffering from acute myeloid leukemia.
AML is one of the most aggressive cancers, and while other cancers have benefited from new treatments, there has been little encouraging news for most leukemia patients for the past 40 years, the researchers said in a statement. Continue Reading »
Israel’s first knee implant, recently performed as part of clinical trials at Hadassah Medical Center in Jerusalem, was the product of Israeli startup Cartiheal and researchers at Ben-Gurion University of the Negev. – Watch video report
The team believe they have found a solution to moderate damage done to the knee, with their unique implant that grows both bone and cartilage.
Israeli PM tells Gautemalan president following volcanic eruption, search & rescue, first aid, recovery provision, anything you need, we’re sending it.
By Arutz Sheva Staff
Israeli Prime Minister Binyamin Netanyahu vowed to assist Guatemala in rescue and recovery efforts, following a devastating earthquake that killed dozens of people earlier this week.
Israel’s ZAKA Search & Rescue volunteeres arrive in Gautemala and begin coordinating with local officials. – Photo courtesy: ZAKA Search & Rescue NGO/Facebook
On Sunday, the Volcan del Fuego volcano southwest of Guatemala City erupted, killing more than 60 people and burying nearby towns in ash.
The National Coordinator for Disaster Reduction in Guatemala said that fiery clouds of smoke were billowing from the volcano and that soot blanketed cars and houses in the nearby villages of San Pedro Yepocapa and Sangre de Cristo. Continue Reading »
Rambam Health Care Campus, serving the over 2 million residents of Northern Israel, will pool its resources to break new ground in medicine along with Stanford University Medical Center, by funding & collaborating in joint R&D projects.
By Ariel Whitman
Haifa’s Rambam Health Care Campus struck a partnership deal with Stanford University Medical Center to encourage research and development entrepreneurship and collaborative projects, Israel Hayom discovered Wednesday.
The heads of the respective hospital agreed to the partnership in the interest of pooling medical resources, time and manpower as well as connecting Silicon Valley with Israel’s burgeoning and innovative high-tech industry. Continue Reading »
This educational website operates without financial incentives. Furthermore, there are no commercial advertisements for profit, nor does it accept donations.
IsraelandStuff.com is truly a 'Labor of Love' with the sole purpose of putting Israel's real face in the light for all to see, while exposing the unfair double-standards, demonization & delegitimization against the only Jewish State.
What ‘Stuff’ can we find for you?
– REMEMBER —-> They are a political group – NOT a ‘people’
Speaking to her ‘brothers’ in Arabic, a proud, courageous Muslim woman reveals the truth about the State of Israel.
(Or do you prefer hearing if from a Muslim man?)
Follow us, We're Everywhere!
View Beautiful Israel
Palestinian History of Violence – The Obstacle to Peace
✡ Support Birthright-Israel ✡
The Time In Jerusalem, ISRAEL is:
Regardless of what the Palestinians, the Arab League, or the corrupt United Nations dictates,
THE WORLD KNOWS THE TRUTH:
Jerusalem is, and has always been, the Eternal Capital of the Jewish People AND the Jewish State of Israel!
Can we get any ‘Greener’? Yes! We can, but we need your help. —————————————————— קקל – Plant a Tree in Israel – JNF
Israel and Stuff shall not be held liable for any delays, inaccuracies, errors or omissions in any content, or for any actions taken in consequence. Israel and Stuff does not obtain release from the subjects, individuals, groups or entities contained in its photographs, graphics or quoted in its text. Further, no clearance is obtained from the owners of any trademarks or copyrighted material where the marks and material are included in photos or content. You shall be solely responsible for obtaining any and all the necessary releases from whatever individual or entity is necessary for any of your uses of Israel and Stuff material. You agree to indemnify Israel and Stuff from any losses, damages and expenses (including attorney fees) it incurs as a result of any claim based on your use of its materials in violation of these terms.
Visitors here (You) are hereby notified that you are strictly prohibited from disclosing, copying, distributing, disseminating, or taking any other action against me with regard to this website and the contents herein. The foregoing prohibitions also apply to your employee(s), agent(s), student(s) or any personnel under your direction or control.
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.